Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Wages, Salaries and Other

Lemaitre Vascular (LMAT) Shares Issued (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Issued for 16 consecutive years, with $2.2 million as the latest value for Q4 2025.

Quarterly Shares Issued rose 75.38% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2025, up 6.61% year-over-year, with the annual reading at $6.8 million for FY2025, 6.61% up from the prior year.
Shares Issued for Q4 2025 was $2.2 million at Lemaitre Vascular, up from $1.6 million in the prior quarter.
The five-year high for Shares Issued was $59.5 million in Q3 2021, with the low at $164000.0 in Q2 2022.
Average Shares Issued over 5 years is $4.5 million, with a median of $1.4 million recorded in 2021.
The sharpest move saw Shares Issued surged 5020.84% in 2021, then tumbled 98.31% in 2022.
Over 5 years, Shares Issued stood at $1.7 million in 2021, then grew by 6.69% to $1.8 million in 2022, then tumbled by 36.93% to $1.1 million in 2023, then grew by 9.58% to $1.2 million in 2024, then soared by 75.38% to $2.2 million in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at $2.2 million, $1.6 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.